B. Riley reissued their buy rating on shares of Altimmune (NASDAQ:ALT – Free Report) in a research note released on Tuesday morning, Benzinga reports. They currently have a $20.00 target price on the stock. A number of other brokerages have also weighed in on ALT. The Goldman Sachs Group started coverage on shares of Altimmune […]
WealthPlan Investment Management LLC purchased a new position in Altimmune, Inc. (NASDAQ:ALT – Free Report) in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 11,931 shares of the company’s stock, valued at approximately $31,000. A number of other institutional investors and hedge funds also […]
Altimmune, Inc. (NASDAQ:ALT – Get Free Report) was up 5.8% during trading on Tuesday . The company traded as high as $10.06 and last traded at $9.93. Approximately 926,426 shares changed hands during mid-day trading, a decline of 85% from the average daily volume of 6,349,605 shares. The stock had previously closed at $9.39. Wall […]
Altimmune (NASDAQ:ALT) Now Covered by The Goldman Sachs Group theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Altimmune, Inc. (NASDAQ:ALT – Get Free Report)’s stock price fell 4.1% during trading on Wednesday . The company traded as low as $9.48 and last traded at $9.61. 1,232,811 shares changed hands during mid-day trading, a decline of 84% from the average session volume of 7,909,166 shares. The stock had previously closed at $10.02. Wall […]